Free tool
Diagnostics stocks
We cover 5 companies grouped under the Diagnostics theme. The median market value in the group is $10.22B. Across the group, the median move over the past trading day is +0.84%. Price change over the past year runs from −24.4% to +14.4% across the middle 80 percent of the group, with a median of −6.7%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
5 of 150 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| ESF0.DE | Eurofins Scientific SE | $14.67B | Large cap | +12.65% |
| ERF.PA | Eurofins Scientific SE | $14.64B | Large cap | +15.60% |
| BIM.PA | bioMérieux S.A. | $10.22B | Large cap | −35.91% |
| QIA.DE | Qiagen N.V. | $8.99B | Mid cap | −6.73% |
| ALIF-B.ST | AddLife AB (publ) | $2.08B | Mid cap | −7.20% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.